Abstract
The protective effect of ischemic postconditioning (IPostC) against stroke has been well-established, and the underlying mechanisms are known to involve inhibited-inflammation and free radical production. Nevertheless, how IPostC affects protein expression of iNOS, nitrotyrosine, and COX-2 has not been characterized. In addition, the role of the galectin-9/Tim-3 cell signaling pathway—a novel inflammatory pathway—in IPostC has not been studied. We examined whether iNOS, nitrotyrosine, and COX-2, as well as galectin-9/Tim-3 are involved in the protective effects of IpostC in a rat focal ischemia model. Western blot and confocal immunofluoresent staining results indicate that IPostC significantly inhibited Tim-3 expression, and that galectin-9 expression was also inhibited. In addition, IPostC attenuated production of iNOS and nitrotyrosine, but not COX-2, suggesting that IPostC has distinct effects on these inflammatory factors. Furthermore, the inflammation inhibitor minocycline blocked Tim-3 and iNOS expression induced by stroke. Taken together, we show that the galectin-9/Tim-3 cell signaling pathway is involved in inflammation induced by stroke, and IPostC may reduce infarction by attenuating this novel pathway as well as the inflammatory factors iNOS and nitrotyrosine, but not COX-2.
Similar content being viewed by others
References
Abas F et al (2010) Neuroprotective effects of postconditioning on lipid peroxidation and apoptosis after focal cerebral ischemia/reperfusion injury in rats. Turk Neurosurg 20:1–8
Anderson AC, Anderson DE (2006) TIM-3 in autoimmunity. Curr Opin Immunol 18:665–669
Anderson AC et al (2007) Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318:1141–1143
Feng R et al (2011) Toll-like receptor 4 is involved in ischemic tolerance of postconditioning in hippocampus of tree shrews to thrombotic cerebral ischemia. Brain Res 1384:118–127
Fox C et al (2005) Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 25:1138–1149
Gao X et al (2008a) Protective effects of ischemic postconditioning compared with gradual reperfusion or preconditioning. J Neurosci Res 86:2505–2511
Gao X et al (2008b) The Akt signaling pathway contributes to postconditioning’s protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 105:943–955
Gielen AW et al (2005) Expression of T cell immunoglobulin- and mucin-domain-containing molecules-1 and −3 (TIM-1 and −3) in the rat nervous and immune systems. J Neuroimmunol 164:93–104
Han HS et al (2002) Influence of mild hypothermia on inducible nitric oxide synthase expression and reactive nitrogen production in experimental stroke and inflammation. J Neurosci 22:3921–3928
Hirabayashi H et al (2000) Nitrotyrosine generation via inducible nitric oxide synthase in vascular wall in focal ischemia-reperfusion. Brain Res 852:319–325
Joo SP et al (2013) Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice. Neuroscience 243:149–157
Karabiyikoglu M et al (2003) Attenuation of nitric oxide synthase isoform expression by mild hypothermia after focal cerebral ischemia: variations depending on timing of cooling. J Neurosurg 98:1271–1276
Koistinaho M et al (2005) Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice. J Cereb Blood Flow Metab 25:460–467
Limbourg FP et al (2002) Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids. J Clin Invest 110:1729–1738
Liu XR et al (2012) Ischemic postconditioning diminishes matrix metalloproteinase 9 expression and attenuates loss of the extracellular matrix proteins in rats following middle cerebral artery occlusion and reperfusion. CNS Neurosci Ther 18:855–863
Martinez-Murillo R et al (2007) The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model. Neurosci Lett 415:149–153
Nakae S et al (2007) TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells. Blood 110:2565–2568
Nanetti L et al (2007) Reactive oxygen species plasmatic levels in ischemic stroke. Mol Cell Biochem 303:19–25
Pignataro G et al (2008) In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 28:232–241
Ren C et al (2008) Delayed postconditioning protects against focal ischemic brain injury in rats. PLoS One 3:e3851
Sanchez-Fueyo A et al (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4:1093–1101
Su EW et al (2008) TIM-1 and TIM-3 proteins in immune regulation. Cytokine 44:9–13
Tang M et al (2010) Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. J Cereb Blood Flow Metab 30:119–129
Wei D et al (2012) The chronic protective effects of limb remote preconditioning and the underlying mechanisms involved in inflammatory factors in rat stroke. PLoS One 7:e30892
Xie R et al (2013) Ischemic post-conditioning facilitates brain recovery after stroke by promoting Akt/mTOR activity in nude rats. J Neurochem 127:723–732
Xing B et al (2008a) Ischemic post-conditioning protects brain and reduces inflammation in a rat model of focal cerebral ischemia/reperfusion. J Neurochem 105:1737–1745
Xing B et al (2008b) Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke 39:2362–2369
Yin W et al (2007) Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 38:1017–1024
Zawadzka M et al (2012) Early steps of microglial activation are directly affected by neuroprotectant FK506 in both in vitro inflammation and in rat model of stroke. J Mol Med 90:1459–1471
Zhao H (2009) Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 29:873–885
Zhao H (2011) The protective effects of ischemic postconditioning against stroke: from rapid to delayed and remote postconditioning. Open Drug Discov J 5:138–147
Zhao H et al (2005) Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 25:9794–9806
Zhao H et al (2006) Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 26:1114–1121
Zhao D et al (2011) Increased T cell immunoglobulin and mucin domain 3 positively correlate with systemic IL-17 and TNF-alpha level in the acute phase of ischemic stroke. J Clin Immunol 31:719–727
Zhao H et al (2012) From rapid to delayed and remote postconditioning: the evolving concept of ischemic postconditioning in brain ischemia. Curr Drug Targets 13:173–187
Acknowledgements
We wish to thank Ms. Elizabeth Hoyte for figure preparation and Ms. Cindy H. Samos for manuscript editing. This study was supported by AHA grant in Aid and 1R01NS 064136–01A1 (HZ).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wei, D., Xiong, X. & Zhao, H. Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats. Metab Brain Dis 30, 483–490 (2015). https://doi.org/10.1007/s11011-014-9543-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9543-2